Noteworthy, discrepancies about the capacity of TGF-β to degrade SKI in melanoma cells have been suggested to be due to the concentrations of TGF-β used in the various studies, and that TGF-β-induced SKI degradation only occurs at "non-physiological" concentrations [68]. The gene discussed is TGFB1; the disease is melanoma.